Global Swine Atrophic Rhinitis Vaccine Supply, Demand and Key Producers, 2026-2032
The global Swine Atrophic Rhinitis Vaccine market size is expected to reach $ 153 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032).
Swine Atrophic Rhinitis Vaccine is a veterinary biological product used to prevent and control swine atrophic rhinitis, progressive atrophic rhinitis and related upper respiratory lesions. It is mainly administered to gilts and sows so that piglets can obtain passive protection through maternally derived antibodies, reducing the risk of turbinate atrophy, sneezing, nasal bleeding, growth retardation and secondary infections. The product is usually based on inactivated Bordetella bronchiseptica cells, Pasteurella multocida toxin or toxoid antigens, and may also be formulated as a combination vaccine with antigens against swine erysipelas, pasteurellosis-related pneumonia and other diseases. Main dosage forms include injectable emulsions or suspensions. Key upstream materials include production strains, bacterial culture media, fermentation consumables, inactivating agents, toxin or toxoid preparation materials, adjuvants, buffers, stabilizers, sterile filling materials, glass or plastic vials, rubber stoppers, aluminum caps, labels and cold-chain packaging materials. Downstream customers mainly include breeding farms, sow farms, large integrated swine producers, commercial pig farms, veterinary service providers, animal health distributors and regional animal disease control procurement channels. On an ex-factory basis, global effective capacity of this product category is estimated at around 390 million doses in 2025, with sales volume of approximately 274 million doses and an average ex-factory price of about USD 0.42 per dose. The industry gross margin in 2025 is estimated at roughly 42%–62%, with multinational brands and combination vaccines usually positioned at the upper end of the range, while regional single vaccines and conventional bacterin-toxoid products are more commonly positioned in the middle to lower part of the range.
The Swine Atrophic Rhinitis Vaccine market is a mature segment within swine respiratory vaccines, with demand mainly supported by continued investment in early piglet health management by breeding farms, sow farms and large-scale swine producers. Although clinical incidence has declined in some high-health-status farms, the disease still requires prevention in regions with uneven biosecurity standards, frequent gilt introduction and high pressure on sow herd management. Current use is increasingly concentrated in sow vaccination and maternally derived antibody protection, with producers focusing more on the indirect benefits of reducing nasal lesions, improving piglet health around weaning and supporting later growth performance. Overall, this is not a high-growth category, but it remains a stable component of basic prevention programs in many swine production systems.
Looking ahead, the market will increasingly upgrade toward combination vaccines and integrated sow immunization programs. The share of standalone atrophic rhinitis vaccines may gradually decline, while combination products linked with swine erysipelas, pasteurellosis-related pneumonia or other bacterial respiratory pathogens are more likely to be accepted by large farms. Breeding farms and large sow units generally prefer to cover more disease risks with fewer vaccinations, reducing labor intensity, lowering handling stress and improving compliance with immunization programs. Product upgrading will mainly focus on toxin antigen processing, toxoid stability, adjuvant safety, maternally derived antibody transfer efficiency and batch consistency. Companies with stable quality control and strong farm-level service capabilities are expected to remain more competitive in this stock-based market.
The main growth drivers come from the industrialization of pig farming, more refined breeding herd health management, standardized sow vaccination programs and producers' increasing attention to early piglet loss control. For high-density farms, nasal lesions, higher respiratory susceptibility and later production performance losses can amplify hidden economic costs, making preventive immunization still valuable. Biosecurity upgrades and frequent herd replacement in some regions also support relatively stable demand from breeding and sow farms. At the same time, multinational animal health companies consolidate the premium market through mature combination vaccines and technical services, while local suppliers compete mainly through cost advantages, channel coverage and regional service capabilities.
Key constraints include lower visible disease awareness, pork price cycles, pressure on farm vaccine budgets and insufficient attention to atrophic rhinitis prevention in some markets. As overall farm management improves, clinical cases may decline in certain regions, putting pressure on standalone vaccine demand. During weak pork price cycles, small and medium-sized farms may prioritize vaccines for diseases with higher morbidity or mortality and reduce purchases of products associated with less visible losses. Differences in veterinary vaccine registration, import approval and batch release requirements across countries also increase the difficulty of cross-regional commercialization. Overall, the market is expected to maintain stable but moderate growth, with the main opportunities coming from combination vaccine substitution, sow immunization program upgrades and regional maintenance of existing demand.
This report studies the global Swine Atrophic Rhinitis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Atrophic Rhinitis Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Atrophic Rhinitis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Atrophic Rhinitis Vaccine total production and demand, 2021-2032, (K Dose)
Global Swine Atrophic Rhinitis Vaccine total production value, 2021-2032, (USD Million)
Global Swine Atrophic Rhinitis Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Swine Atrophic Rhinitis Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Swine Atrophic Rhinitis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Atrophic Rhinitis Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Swine Atrophic Rhinitis Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Swine Atrophic Rhinitis Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Swine Atrophic Rhinitis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, HIPRA, Elanco Animal Health, Virbac, Bioveta, Nisseiken, Kyoto Biken Laboratories, KBNP, Wuhan Keqian Biology, Pulike Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Atrophic Rhinitis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Swine Atrophic Rhinitis Vaccine Market, By Region:
1. How big is the global Swine Atrophic Rhinitis Vaccine market?
2. What is the demand of the global Swine Atrophic Rhinitis Vaccine market?
3. What is the year over year growth of the global Swine Atrophic Rhinitis Vaccine market?
4. What is the production and production value of the global Swine Atrophic Rhinitis Vaccine market?
5. Who are the key producers in the global Swine Atrophic Rhinitis Vaccine market?
6. What are the growth factors driving the market demand?
Swine Atrophic Rhinitis Vaccine is a veterinary biological product used to prevent and control swine atrophic rhinitis, progressive atrophic rhinitis and related upper respiratory lesions. It is mainly administered to gilts and sows so that piglets can obtain passive protection through maternally derived antibodies, reducing the risk of turbinate atrophy, sneezing, nasal bleeding, growth retardation and secondary infections. The product is usually based on inactivated Bordetella bronchiseptica cells, Pasteurella multocida toxin or toxoid antigens, and may also be formulated as a combination vaccine with antigens against swine erysipelas, pasteurellosis-related pneumonia and other diseases. Main dosage forms include injectable emulsions or suspensions. Key upstream materials include production strains, bacterial culture media, fermentation consumables, inactivating agents, toxin or toxoid preparation materials, adjuvants, buffers, stabilizers, sterile filling materials, glass or plastic vials, rubber stoppers, aluminum caps, labels and cold-chain packaging materials. Downstream customers mainly include breeding farms, sow farms, large integrated swine producers, commercial pig farms, veterinary service providers, animal health distributors and regional animal disease control procurement channels. On an ex-factory basis, global effective capacity of this product category is estimated at around 390 million doses in 2025, with sales volume of approximately 274 million doses and an average ex-factory price of about USD 0.42 per dose. The industry gross margin in 2025 is estimated at roughly 42%–62%, with multinational brands and combination vaccines usually positioned at the upper end of the range, while regional single vaccines and conventional bacterin-toxoid products are more commonly positioned in the middle to lower part of the range.
The Swine Atrophic Rhinitis Vaccine market is a mature segment within swine respiratory vaccines, with demand mainly supported by continued investment in early piglet health management by breeding farms, sow farms and large-scale swine producers. Although clinical incidence has declined in some high-health-status farms, the disease still requires prevention in regions with uneven biosecurity standards, frequent gilt introduction and high pressure on sow herd management. Current use is increasingly concentrated in sow vaccination and maternally derived antibody protection, with producers focusing more on the indirect benefits of reducing nasal lesions, improving piglet health around weaning and supporting later growth performance. Overall, this is not a high-growth category, but it remains a stable component of basic prevention programs in many swine production systems.
Looking ahead, the market will increasingly upgrade toward combination vaccines and integrated sow immunization programs. The share of standalone atrophic rhinitis vaccines may gradually decline, while combination products linked with swine erysipelas, pasteurellosis-related pneumonia or other bacterial respiratory pathogens are more likely to be accepted by large farms. Breeding farms and large sow units generally prefer to cover more disease risks with fewer vaccinations, reducing labor intensity, lowering handling stress and improving compliance with immunization programs. Product upgrading will mainly focus on toxin antigen processing, toxoid stability, adjuvant safety, maternally derived antibody transfer efficiency and batch consistency. Companies with stable quality control and strong farm-level service capabilities are expected to remain more competitive in this stock-based market.
The main growth drivers come from the industrialization of pig farming, more refined breeding herd health management, standardized sow vaccination programs and producers' increasing attention to early piglet loss control. For high-density farms, nasal lesions, higher respiratory susceptibility and later production performance losses can amplify hidden economic costs, making preventive immunization still valuable. Biosecurity upgrades and frequent herd replacement in some regions also support relatively stable demand from breeding and sow farms. At the same time, multinational animal health companies consolidate the premium market through mature combination vaccines and technical services, while local suppliers compete mainly through cost advantages, channel coverage and regional service capabilities.
Key constraints include lower visible disease awareness, pork price cycles, pressure on farm vaccine budgets and insufficient attention to atrophic rhinitis prevention in some markets. As overall farm management improves, clinical cases may decline in certain regions, putting pressure on standalone vaccine demand. During weak pork price cycles, small and medium-sized farms may prioritize vaccines for diseases with higher morbidity or mortality and reduce purchases of products associated with less visible losses. Differences in veterinary vaccine registration, import approval and batch release requirements across countries also increase the difficulty of cross-regional commercialization. Overall, the market is expected to maintain stable but moderate growth, with the main opportunities coming from combination vaccine substitution, sow immunization program upgrades and regional maintenance of existing demand.
This report studies the global Swine Atrophic Rhinitis Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Swine Atrophic Rhinitis Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Swine Atrophic Rhinitis Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Swine Atrophic Rhinitis Vaccine total production and demand, 2021-2032, (K Dose)
Global Swine Atrophic Rhinitis Vaccine total production value, 2021-2032, (USD Million)
Global Swine Atrophic Rhinitis Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Swine Atrophic Rhinitis Vaccine consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Swine Atrophic Rhinitis Vaccine domestic production, consumption, key domestic manufacturers and share
Global Swine Atrophic Rhinitis Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Swine Atrophic Rhinitis Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Swine Atrophic Rhinitis Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Swine Atrophic Rhinitis Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck Animal Health, HIPRA, Elanco Animal Health, Virbac, Bioveta, Nisseiken, Kyoto Biken Laboratories, KBNP, Wuhan Keqian Biology, Pulike Biological Engineering, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Swine Atrophic Rhinitis Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Swine Atrophic Rhinitis Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Single Vaccine
- Dual Vaccine
- Others
- Gilts
- Sows
- Piglets
- Other
- Small Pack (Below 20 Doses per Vial)
- Medium Pack (20–50 Doses per Vial)
- Large Pack (Above 50 Doses per Vial)
- Large-scale Pig Farming Groups
- Breeding Pig Farms
- Veterinary Service Providers
- Others
- Merck Animal Health
- HIPRA
- Elanco Animal Health
- Virbac
- Bioveta
- Nisseiken
- Kyoto Biken Laboratories
- KBNP
- Wuhan Keqian Biology
- Pulike Biological Engineering
1. How big is the global Swine Atrophic Rhinitis Vaccine market?
2. What is the demand of the global Swine Atrophic Rhinitis Vaccine market?
3. What is the year over year growth of the global Swine Atrophic Rhinitis Vaccine market?
4. What is the production and production value of the global Swine Atrophic Rhinitis Vaccine market?
5. Who are the key producers in the global Swine Atrophic Rhinitis Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Swine Atrophic Rhinitis Vaccine Introduction
1.2 World Swine Atrophic Rhinitis Vaccine Supply & Forecast
1.2.1 World Swine Atrophic Rhinitis Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.2.3 World Swine Atrophic Rhinitis Vaccine Pricing Trends (2021-2032)
1.3 World Swine Atrophic Rhinitis Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021-2032)
1.3.2 World Swine Atrophic Rhinitis Vaccine Production by Region (2021-2032)
1.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Region (2021-2032)
1.3.4 North America Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.5 Europe Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.6 China Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.7 Japan Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Atrophic Rhinitis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Atrophic Rhinitis Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Swine Atrophic Rhinitis Vaccine Demand (2021-2032)
2.2 World Swine Atrophic Rhinitis Vaccine Consumption by Region
2.2.1 World Swine Atrophic Rhinitis Vaccine Consumption by Region (2021-2026)
2.2.2 World Swine Atrophic Rhinitis Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.4 China Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.5 Europe Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.6 Japan Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.7 South Korea Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.8 ASEAN Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.9 India Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Atrophic Rhinitis Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Swine Atrophic Rhinitis Vaccine Production by Manufacturer (2021-2026)
3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Manufacturer (2021-2026)
3.4 Swine Atrophic Rhinitis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Atrophic Rhinitis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Atrophic Rhinitis Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Swine Atrophic Rhinitis Vaccine in 2025
3.6 Swine Atrophic Rhinitis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Atrophic Rhinitis Vaccine Market: Region Footprint
3.6.2 Swine Atrophic Rhinitis Vaccine Market: Company Product Type Footprint
3.6.3 Swine Atrophic Rhinitis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Comparison
4.2.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
4.5 China Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
4.6 Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Vaccine
5.2.2 Dual Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Swine Atrophic Rhinitis Vaccine Production by Type (2021-2032)
5.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Type (2021-2032)
5.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET ANIMAL
6.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Target Animal: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Animal
6.2.1 Gilts
6.2.2 Sows
6.2.3 Piglets
6.2.4 Other
6.3 Market Segment by Target Animal
6.3.1 World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2021-2032)
6.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2021-2032)
6.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Pig Farming Groups
8.2.2 Breeding Pig Farms
8.2.3 Veterinary Service Providers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Swine Atrophic Rhinitis Vaccine Production by Application (2021-2032)
8.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Application (2021-2032)
8.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck Animal Health
9.1.1 Merck Animal Health Details
9.1.2 Merck Animal Health Major Business
9.1.3 Merck Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
9.1.4 Merck Animal Health Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Animal Health Recent Developments/Updates
9.1.6 Merck Animal Health Competitive Strengths & Weaknesses
9.2 HIPRA
9.2.1 HIPRA Details
9.2.2 HIPRA Major Business
9.2.3 HIPRA Swine Atrophic Rhinitis Vaccine Product and Services
9.2.4 HIPRA Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 HIPRA Recent Developments/Updates
9.2.6 HIPRA Competitive Strengths & Weaknesses
9.3 Elanco Animal Health
9.3.1 Elanco Animal Health Details
9.3.2 Elanco Animal Health Major Business
9.3.3 Elanco Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
9.3.4 Elanco Animal Health Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Elanco Animal Health Recent Developments/Updates
9.3.6 Elanco Animal Health Competitive Strengths & Weaknesses
9.4 Virbac
9.4.1 Virbac Details
9.4.2 Virbac Major Business
9.4.3 Virbac Swine Atrophic Rhinitis Vaccine Product and Services
9.4.4 Virbac Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Virbac Recent Developments/Updates
9.4.6 Virbac Competitive Strengths & Weaknesses
9.5 Bioveta
9.5.1 Bioveta Details
9.5.2 Bioveta Major Business
9.5.3 Bioveta Swine Atrophic Rhinitis Vaccine Product and Services
9.5.4 Bioveta Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bioveta Recent Developments/Updates
9.5.6 Bioveta Competitive Strengths & Weaknesses
9.6 Nisseiken
9.6.1 Nisseiken Details
9.6.2 Nisseiken Major Business
9.6.3 Nisseiken Swine Atrophic Rhinitis Vaccine Product and Services
9.6.4 Nisseiken Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Nisseiken Recent Developments/Updates
9.6.6 Nisseiken Competitive Strengths & Weaknesses
9.7 Kyoto Biken Laboratories
9.7.1 Kyoto Biken Laboratories Details
9.7.2 Kyoto Biken Laboratories Major Business
9.7.3 Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Product and Services
9.7.4 Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Kyoto Biken Laboratories Recent Developments/Updates
9.7.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
9.8 KBNP
9.8.1 KBNP Details
9.8.2 KBNP Major Business
9.8.3 KBNP Swine Atrophic Rhinitis Vaccine Product and Services
9.8.4 KBNP Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 KBNP Recent Developments/Updates
9.8.6 KBNP Competitive Strengths & Weaknesses
9.9 Wuhan Keqian Biology
9.9.1 Wuhan Keqian Biology Details
9.9.2 Wuhan Keqian Biology Major Business
9.9.3 Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Product and Services
9.9.4 Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wuhan Keqian Biology Recent Developments/Updates
9.9.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
9.10 Pulike Biological Engineering
9.10.1 Pulike Biological Engineering Details
9.10.2 Pulike Biological Engineering Major Business
9.10.3 Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Product and Services
9.10.4 Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Pulike Biological Engineering Recent Developments/Updates
9.10.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Swine Atrophic Rhinitis Vaccine Industry Chain
10.2 Swine Atrophic Rhinitis Vaccine Upstream Analysis
10.2.1 Swine Atrophic Rhinitis Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Swine Atrophic Rhinitis Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Swine Atrophic Rhinitis Vaccine Production Mode
10.6 Swine Atrophic Rhinitis Vaccine Procurement Model
10.7 Swine Atrophic Rhinitis Vaccine Industry Sales Model and Sales Channels
10.7.1 Swine Atrophic Rhinitis Vaccine Sales Model
10.7.2 Swine Atrophic Rhinitis Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Swine Atrophic Rhinitis Vaccine Introduction
1.2 World Swine Atrophic Rhinitis Vaccine Supply & Forecast
1.2.1 World Swine Atrophic Rhinitis Vaccine Production Value (2021 & 2025 & 2032)
1.2.2 World Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.2.3 World Swine Atrophic Rhinitis Vaccine Pricing Trends (2021-2032)
1.3 World Swine Atrophic Rhinitis Vaccine Production by Region (Based on Production Site)
1.3.1 World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021-2032)
1.3.2 World Swine Atrophic Rhinitis Vaccine Production by Region (2021-2032)
1.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Region (2021-2032)
1.3.4 North America Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.5 Europe Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.6 China Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.3.7 Japan Swine Atrophic Rhinitis Vaccine Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Swine Atrophic Rhinitis Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Swine Atrophic Rhinitis Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World Swine Atrophic Rhinitis Vaccine Demand (2021-2032)
2.2 World Swine Atrophic Rhinitis Vaccine Consumption by Region
2.2.1 World Swine Atrophic Rhinitis Vaccine Consumption by Region (2021-2026)
2.2.2 World Swine Atrophic Rhinitis Vaccine Consumption Forecast by Region (2027-2032)
2.3 United States Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.4 China Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.5 Europe Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.6 Japan Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.7 South Korea Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.8 ASEAN Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
2.9 India Swine Atrophic Rhinitis Vaccine Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Swine Atrophic Rhinitis Vaccine Production Value by Manufacturer (2021-2026)
3.2 World Swine Atrophic Rhinitis Vaccine Production by Manufacturer (2021-2026)
3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Manufacturer (2021-2026)
3.4 Swine Atrophic Rhinitis Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Swine Atrophic Rhinitis Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Swine Atrophic Rhinitis Vaccine in 2025
3.5.3 Global Concentration Ratios (CR8) for Swine Atrophic Rhinitis Vaccine in 2025
3.6 Swine Atrophic Rhinitis Vaccine Market: Overall Company Footprint Analysis
3.6.1 Swine Atrophic Rhinitis Vaccine Market: Region Footprint
3.6.2 Swine Atrophic Rhinitis Vaccine Market: Company Product Type Footprint
3.6.3 Swine Atrophic Rhinitis Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Comparison
4.1.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Comparison
4.2.1 United States VS China: Swine Atrophic Rhinitis Vaccine Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Swine Atrophic Rhinitis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Comparison
4.3.1 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.4.3 United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
4.5 China Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share
4.5.1 China Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.5.3 China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
4.6 Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Single Vaccine
5.2.2 Dual Vaccine
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Swine Atrophic Rhinitis Vaccine Production by Type (2021-2032)
5.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Type (2021-2032)
5.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY TARGET ANIMAL
6.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Target Animal: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Target Animal
6.2.1 Gilts
6.2.2 Sows
6.2.3 Piglets
6.2.4 Other
6.3 Market Segment by Target Animal
6.3.1 World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2021-2032)
6.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2021-2032)
6.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2032)
7 MARKET ANALYSIS BY DOSE PACK SIZE
7.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Dose Pack Size: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Dose Pack Size
7.2.1 Small Pack (Below 20 Doses per Vial)
7.2.2 Medium Pack (20–50 Doses per Vial)
7.2.3 Large Pack (Above 50 Doses per Vial)
7.3 Market Segment by Dose Pack Size
7.3.1 World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2021-2032)
7.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2021-2032)
7.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Swine Atrophic Rhinitis Vaccine Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large-scale Pig Farming Groups
8.2.2 Breeding Pig Farms
8.2.3 Veterinary Service Providers
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Swine Atrophic Rhinitis Vaccine Production by Application (2021-2032)
8.3.2 World Swine Atrophic Rhinitis Vaccine Production Value by Application (2021-2032)
8.3.3 World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck Animal Health
9.1.1 Merck Animal Health Details
9.1.2 Merck Animal Health Major Business
9.1.3 Merck Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
9.1.4 Merck Animal Health Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Animal Health Recent Developments/Updates
9.1.6 Merck Animal Health Competitive Strengths & Weaknesses
9.2 HIPRA
9.2.1 HIPRA Details
9.2.2 HIPRA Major Business
9.2.3 HIPRA Swine Atrophic Rhinitis Vaccine Product and Services
9.2.4 HIPRA Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 HIPRA Recent Developments/Updates
9.2.6 HIPRA Competitive Strengths & Weaknesses
9.3 Elanco Animal Health
9.3.1 Elanco Animal Health Details
9.3.2 Elanco Animal Health Major Business
9.3.3 Elanco Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
9.3.4 Elanco Animal Health Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Elanco Animal Health Recent Developments/Updates
9.3.6 Elanco Animal Health Competitive Strengths & Weaknesses
9.4 Virbac
9.4.1 Virbac Details
9.4.2 Virbac Major Business
9.4.3 Virbac Swine Atrophic Rhinitis Vaccine Product and Services
9.4.4 Virbac Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Virbac Recent Developments/Updates
9.4.6 Virbac Competitive Strengths & Weaknesses
9.5 Bioveta
9.5.1 Bioveta Details
9.5.2 Bioveta Major Business
9.5.3 Bioveta Swine Atrophic Rhinitis Vaccine Product and Services
9.5.4 Bioveta Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Bioveta Recent Developments/Updates
9.5.6 Bioveta Competitive Strengths & Weaknesses
9.6 Nisseiken
9.6.1 Nisseiken Details
9.6.2 Nisseiken Major Business
9.6.3 Nisseiken Swine Atrophic Rhinitis Vaccine Product and Services
9.6.4 Nisseiken Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Nisseiken Recent Developments/Updates
9.6.6 Nisseiken Competitive Strengths & Weaknesses
9.7 Kyoto Biken Laboratories
9.7.1 Kyoto Biken Laboratories Details
9.7.2 Kyoto Biken Laboratories Major Business
9.7.3 Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Product and Services
9.7.4 Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Kyoto Biken Laboratories Recent Developments/Updates
9.7.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
9.8 KBNP
9.8.1 KBNP Details
9.8.2 KBNP Major Business
9.8.3 KBNP Swine Atrophic Rhinitis Vaccine Product and Services
9.8.4 KBNP Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 KBNP Recent Developments/Updates
9.8.6 KBNP Competitive Strengths & Weaknesses
9.9 Wuhan Keqian Biology
9.9.1 Wuhan Keqian Biology Details
9.9.2 Wuhan Keqian Biology Major Business
9.9.3 Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Product and Services
9.9.4 Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Wuhan Keqian Biology Recent Developments/Updates
9.9.6 Wuhan Keqian Biology Competitive Strengths & Weaknesses
9.10 Pulike Biological Engineering
9.10.1 Pulike Biological Engineering Details
9.10.2 Pulike Biological Engineering Major Business
9.10.3 Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Product and Services
9.10.4 Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Pulike Biological Engineering Recent Developments/Updates
9.10.6 Pulike Biological Engineering Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Swine Atrophic Rhinitis Vaccine Industry Chain
10.2 Swine Atrophic Rhinitis Vaccine Upstream Analysis
10.2.1 Swine Atrophic Rhinitis Vaccine Core Raw Materials
10.2.2 Main Manufacturers of Swine Atrophic Rhinitis Vaccine Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Swine Atrophic Rhinitis Vaccine Production Mode
10.6 Swine Atrophic Rhinitis Vaccine Procurement Model
10.7 Swine Atrophic Rhinitis Vaccine Industry Sales Model and Sales Channels
10.7.1 Swine Atrophic Rhinitis Vaccine Sales Model
10.7.2 Swine Atrophic Rhinitis Vaccine Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Swine Atrophic Rhinitis Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Swine Atrophic Rhinitis Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2021-2026)
Table 9. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2027-2032)
Table 10. World Swine Atrophic Rhinitis Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Swine Atrophic Rhinitis Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Swine Atrophic Rhinitis Vaccine Major Market Trends
Table 13. World Swine Atrophic Rhinitis Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Swine Atrophic Rhinitis Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Swine Atrophic Rhinitis Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Swine Atrophic Rhinitis Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Swine Atrophic Rhinitis Vaccine Producers in 2025
Table 18. World Swine Atrophic Rhinitis Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Swine Atrophic Rhinitis Vaccine Producers in 2025
Table 20. World Swine Atrophic Rhinitis Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Swine Atrophic Rhinitis Vaccine Company Evaluation Quadrant
Table 22. World Swine Atrophic Rhinitis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Swine Atrophic Rhinitis Vaccine Production Site of Key Manufacturer
Table 24. Swine Atrophic Rhinitis Vaccine Market: Company Product Type Footprint
Table 25. Swine Atrophic Rhinitis Vaccine Market: Company Product Application Footprint
Table 26. Swine Atrophic Rhinitis Vaccine Competitive Factors
Table 27. Swine Atrophic Rhinitis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Atrophic Rhinitis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Atrophic Rhinitis Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Swine Atrophic Rhinitis Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Swine Atrophic Rhinitis Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 37. China Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 47. World Swine Atrophic Rhinitis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Swine Atrophic Rhinitis Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Swine Atrophic Rhinitis Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Swine Atrophic Rhinitis Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Swine Atrophic Rhinitis Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal, (USD Million), 2021 & 2025 & 2032
Table 55. World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2021-2026) & (K Dose)
Table 56. World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2027-2032) & (K Dose)
Table 57. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2021-2026) & (USD Million)
Table 58. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2027-2032) & (USD Million)
Table 59. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2026) & (US$/Dose)
Table 60. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2027-2032) & (US$/Dose)
Table 61. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Swine Atrophic Rhinitis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Swine Atrophic Rhinitis Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Swine Atrophic Rhinitis Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Swine Atrophic Rhinitis Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Swine Atrophic Rhinitis Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 76. Merck Animal Health Major Business
Table 77. Merck Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
Table 78. Merck Animal Health Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Merck Animal Health Competitive Strengths & Weaknesses
Table 81. HIPRA Basic Information, Manufacturing Base and Competitors
Table 82. HIPRA Major Business
Table 83. HIPRA Swine Atrophic Rhinitis Vaccine Product and Services
Table 84. HIPRA Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. HIPRA Recent Developments/Updates
Table 86. HIPRA Competitive Strengths & Weaknesses
Table 87. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 88. Elanco Animal Health Major Business
Table 89. Elanco Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
Table 90. Elanco Animal Health Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Elanco Animal Health Recent Developments/Updates
Table 92. Elanco Animal Health Competitive Strengths & Weaknesses
Table 93. Virbac Basic Information, Manufacturing Base and Competitors
Table 94. Virbac Major Business
Table 95. Virbac Swine Atrophic Rhinitis Vaccine Product and Services
Table 96. Virbac Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Virbac Recent Developments/Updates
Table 98. Virbac Competitive Strengths & Weaknesses
Table 99. Bioveta Basic Information, Manufacturing Base and Competitors
Table 100. Bioveta Major Business
Table 101. Bioveta Swine Atrophic Rhinitis Vaccine Product and Services
Table 102. Bioveta Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bioveta Recent Developments/Updates
Table 104. Bioveta Competitive Strengths & Weaknesses
Table 105. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 106. Nisseiken Major Business
Table 107. Nisseiken Swine Atrophic Rhinitis Vaccine Product and Services
Table 108. Nisseiken Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Nisseiken Recent Developments/Updates
Table 110. Nisseiken Competitive Strengths & Weaknesses
Table 111. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 112. Kyoto Biken Laboratories Major Business
Table 113. Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Product and Services
Table 114. Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Kyoto Biken Laboratories Recent Developments/Updates
Table 116. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 117. KBNP Basic Information, Manufacturing Base and Competitors
Table 118. KBNP Major Business
Table 119. KBNP Swine Atrophic Rhinitis Vaccine Product and Services
Table 120. KBNP Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. KBNP Recent Developments/Updates
Table 122. KBNP Competitive Strengths & Weaknesses
Table 123. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 124. Wuhan Keqian Biology Major Business
Table 125. Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Product and Services
Table 126. Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wuhan Keqian Biology Recent Developments/Updates
Table 128. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 129. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 130. Pulike Biological Engineering Major Business
Table 131. Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Product and Services
Table 132. Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Pulike Biological Engineering Recent Developments/Updates
Table 134. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 135. Global Key Players of Swine Atrophic Rhinitis Vaccine Upstream (Raw Materials)
Table 136. Global Swine Atrophic Rhinitis Vaccine Typical Customers
Table 137. Swine Atrophic Rhinitis Vaccine Typical Distributors
Table 1. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2021-2026) & (USD Million)
Table 3. World Swine Atrophic Rhinitis Vaccine Production Value by Region (2027-2032) & (USD Million)
Table 4. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2021-2026)
Table 5. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2027-2032)
Table 6. World Swine Atrophic Rhinitis Vaccine Production by Region (2021-2026) & (K Dose)
Table 7. World Swine Atrophic Rhinitis Vaccine Production by Region (2027-2032) & (K Dose)
Table 8. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2021-2026)
Table 9. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2027-2032)
Table 10. World Swine Atrophic Rhinitis Vaccine Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World Swine Atrophic Rhinitis Vaccine Average Price by Region (2027-2032) & (US$/Dose)
Table 12. Swine Atrophic Rhinitis Vaccine Major Market Trends
Table 13. World Swine Atrophic Rhinitis Vaccine Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Swine Atrophic Rhinitis Vaccine Consumption by Region (2021-2026) & (K Dose)
Table 15. World Swine Atrophic Rhinitis Vaccine Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Swine Atrophic Rhinitis Vaccine Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Swine Atrophic Rhinitis Vaccine Producers in 2025
Table 18. World Swine Atrophic Rhinitis Vaccine Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Swine Atrophic Rhinitis Vaccine Producers in 2025
Table 20. World Swine Atrophic Rhinitis Vaccine Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global Swine Atrophic Rhinitis Vaccine Company Evaluation Quadrant
Table 22. World Swine Atrophic Rhinitis Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Swine Atrophic Rhinitis Vaccine Production Site of Key Manufacturer
Table 24. Swine Atrophic Rhinitis Vaccine Market: Company Product Type Footprint
Table 25. Swine Atrophic Rhinitis Vaccine Market: Company Product Application Footprint
Table 26. Swine Atrophic Rhinitis Vaccine Competitive Factors
Table 27. Swine Atrophic Rhinitis Vaccine New Entrant and Capacity Expansion Plans
Table 28. Swine Atrophic Rhinitis Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Swine Atrophic Rhinitis Vaccine Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Swine Atrophic Rhinitis Vaccine Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Swine Atrophic Rhinitis Vaccine Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 37. China Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 42. Rest of World Based Swine Atrophic Rhinitis Vaccine Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share (2021-2026)
Table 47. World Swine Atrophic Rhinitis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Swine Atrophic Rhinitis Vaccine Production by Type (2021-2026) & (K Dose)
Table 49. World Swine Atrophic Rhinitis Vaccine Production by Type (2027-2032) & (K Dose)
Table 50. World Swine Atrophic Rhinitis Vaccine Production Value by Type (2021-2026) & (USD Million)
Table 51. World Swine Atrophic Rhinitis Vaccine Production Value by Type (2027-2032) & (USD Million)
Table 52. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal, (USD Million), 2021 & 2025 & 2032
Table 55. World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2021-2026) & (K Dose)
Table 56. World Swine Atrophic Rhinitis Vaccine Production by Target Animal (2027-2032) & (K Dose)
Table 57. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2021-2026) & (USD Million)
Table 58. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal (2027-2032) & (USD Million)
Table 59. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2026) & (US$/Dose)
Table 60. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2027-2032) & (US$/Dose)
Table 61. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Table 62. World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2021-2026) & (K Dose)
Table 63. World Swine Atrophic Rhinitis Vaccine Production by Dose Pack Size (2027-2032) & (K Dose)
Table 64. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2021-2026) & (USD Million)
Table 65. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size (2027-2032) & (USD Million)
Table 66. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2026) & (US$/Dose)
Table 67. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2027-2032) & (US$/Dose)
Table 68. World Swine Atrophic Rhinitis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Swine Atrophic Rhinitis Vaccine Production by Application (2021-2026) & (K Dose)
Table 70. World Swine Atrophic Rhinitis Vaccine Production by Application (2027-2032) & (K Dose)
Table 71. World Swine Atrophic Rhinitis Vaccine Production Value by Application (2021-2026) & (USD Million)
Table 72. World Swine Atrophic Rhinitis Vaccine Production Value by Application (2027-2032) & (USD Million)
Table 73. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2026) & (US$/Dose)
Table 74. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2027-2032) & (US$/Dose)
Table 75. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 76. Merck Animal Health Major Business
Table 77. Merck Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
Table 78. Merck Animal Health Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Merck Animal Health Competitive Strengths & Weaknesses
Table 81. HIPRA Basic Information, Manufacturing Base and Competitors
Table 82. HIPRA Major Business
Table 83. HIPRA Swine Atrophic Rhinitis Vaccine Product and Services
Table 84. HIPRA Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. HIPRA Recent Developments/Updates
Table 86. HIPRA Competitive Strengths & Weaknesses
Table 87. Elanco Animal Health Basic Information, Manufacturing Base and Competitors
Table 88. Elanco Animal Health Major Business
Table 89. Elanco Animal Health Swine Atrophic Rhinitis Vaccine Product and Services
Table 90. Elanco Animal Health Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Elanco Animal Health Recent Developments/Updates
Table 92. Elanco Animal Health Competitive Strengths & Weaknesses
Table 93. Virbac Basic Information, Manufacturing Base and Competitors
Table 94. Virbac Major Business
Table 95. Virbac Swine Atrophic Rhinitis Vaccine Product and Services
Table 96. Virbac Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Virbac Recent Developments/Updates
Table 98. Virbac Competitive Strengths & Weaknesses
Table 99. Bioveta Basic Information, Manufacturing Base and Competitors
Table 100. Bioveta Major Business
Table 101. Bioveta Swine Atrophic Rhinitis Vaccine Product and Services
Table 102. Bioveta Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Bioveta Recent Developments/Updates
Table 104. Bioveta Competitive Strengths & Weaknesses
Table 105. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 106. Nisseiken Major Business
Table 107. Nisseiken Swine Atrophic Rhinitis Vaccine Product and Services
Table 108. Nisseiken Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Nisseiken Recent Developments/Updates
Table 110. Nisseiken Competitive Strengths & Weaknesses
Table 111. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 112. Kyoto Biken Laboratories Major Business
Table 113. Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Product and Services
Table 114. Kyoto Biken Laboratories Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Kyoto Biken Laboratories Recent Developments/Updates
Table 116. Kyoto Biken Laboratories Competitive Strengths & Weaknesses
Table 117. KBNP Basic Information, Manufacturing Base and Competitors
Table 118. KBNP Major Business
Table 119. KBNP Swine Atrophic Rhinitis Vaccine Product and Services
Table 120. KBNP Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. KBNP Recent Developments/Updates
Table 122. KBNP Competitive Strengths & Weaknesses
Table 123. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 124. Wuhan Keqian Biology Major Business
Table 125. Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Product and Services
Table 126. Wuhan Keqian Biology Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Wuhan Keqian Biology Recent Developments/Updates
Table 128. Wuhan Keqian Biology Competitive Strengths & Weaknesses
Table 129. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 130. Pulike Biological Engineering Major Business
Table 131. Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Product and Services
Table 132. Pulike Biological Engineering Swine Atrophic Rhinitis Vaccine Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Pulike Biological Engineering Recent Developments/Updates
Table 134. Pulike Biological Engineering Competitive Strengths & Weaknesses
Table 135. Global Key Players of Swine Atrophic Rhinitis Vaccine Upstream (Raw Materials)
Table 136. Global Swine Atrophic Rhinitis Vaccine Typical Customers
Table 137. Swine Atrophic Rhinitis Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Swine Atrophic Rhinitis Vaccine Picture
Figure 2. World Swine Atrophic Rhinitis Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Swine Atrophic Rhinitis Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Swine Atrophic Rhinitis Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 12. Swine Atrophic Rhinitis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Swine Atrophic Rhinitis Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Swine Atrophic Rhinitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Atrophic Rhinitis Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Atrophic Rhinitis Vaccine Markets in 2025
Figure 26. United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Swine Atrophic Rhinitis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 32. World Swine Atrophic Rhinitis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Type in 2025
Figure 34. Single Vaccine
Figure 35. Dual Vaccine
Figure 36. Others
Figure 37. World Swine Atrophic Rhinitis Vaccine Production Market Share by Type (2021-2032)
Figure 38. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Type (2021-2032)
Figure 39. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal, (USD Million), 2021 & 2025 & 2032
Figure 41. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Target Animal in 2025
Figure 42. Gilts
Figure 43. Sows
Figure 44. Piglets
Figure 45. Other
Figure 46. World Swine Atrophic Rhinitis Vaccine Production Market Share by Target Animal (2021-2032)
Figure 47. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Target Animal (2021-2032)
Figure 48. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2032) & (US$/Dose)
Figure 49. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 50. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 51. Small Pack (Below 20 Doses per Vial)
Figure 52. Medium Pack (20–50 Doses per Vial)
Figure 53. Large Pack (Above 50 Doses per Vial)
Figure 54. World Swine Atrophic Rhinitis Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 55. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 56. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 57. World Swine Atrophic Rhinitis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Application in 2025
Figure 59. Large-scale Pig Farming Groups
Figure 60. Breeding Pig Farms
Figure 61. Veterinary Service Providers
Figure 62. Others
Figure 63. World Swine Atrophic Rhinitis Vaccine Production Market Share by Application (2021-2032)
Figure 64. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Application (2021-2032)
Figure 65. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 66. Swine Atrophic Rhinitis Vaccine Industry Chain
Figure 67. Swine Atrophic Rhinitis Vaccine Procurement Model
Figure 68. Swine Atrophic Rhinitis Vaccine Sales Model
Figure 69. Swine Atrophic Rhinitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Swine Atrophic Rhinitis Vaccine Picture
Figure 2. World Swine Atrophic Rhinitis Vaccine Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Swine Atrophic Rhinitis Vaccine Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 5. World Swine Atrophic Rhinitis Vaccine Average Price (2021-2032) & (US$/Dose)
Figure 6. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Region (2021-2032)
Figure 7. World Swine Atrophic Rhinitis Vaccine Production Market Share by Region (2021-2032)
Figure 8. North America Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 9. Europe Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 10. China Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 11. Japan Swine Atrophic Rhinitis Vaccine Production (2021-2032) & (K Dose)
Figure 12. Swine Atrophic Rhinitis Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 15. World Swine Atrophic Rhinitis Vaccine Consumption Market Share by Region (2021-2032)
Figure 16. United States Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 17. China Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 18. Europe Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 19. Japan Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 22. India Swine Atrophic Rhinitis Vaccine Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Swine Atrophic Rhinitis Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Swine Atrophic Rhinitis Vaccine Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Swine Atrophic Rhinitis Vaccine Markets in 2025
Figure 26. United States VS China: Swine Atrophic Rhinitis Vaccine Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Swine Atrophic Rhinitis Vaccine Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Swine Atrophic Rhinitis Vaccine Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 30. China Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Swine Atrophic Rhinitis Vaccine Production Market Share 2025
Figure 32. World Swine Atrophic Rhinitis Vaccine Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Type in 2025
Figure 34. Single Vaccine
Figure 35. Dual Vaccine
Figure 36. Others
Figure 37. World Swine Atrophic Rhinitis Vaccine Production Market Share by Type (2021-2032)
Figure 38. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Type (2021-2032)
Figure 39. World Swine Atrophic Rhinitis Vaccine Average Price by Type (2021-2032) & (US$/Dose)
Figure 40. World Swine Atrophic Rhinitis Vaccine Production Value by Target Animal, (USD Million), 2021 & 2025 & 2032
Figure 41. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Target Animal in 2025
Figure 42. Gilts
Figure 43. Sows
Figure 44. Piglets
Figure 45. Other
Figure 46. World Swine Atrophic Rhinitis Vaccine Production Market Share by Target Animal (2021-2032)
Figure 47. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Target Animal (2021-2032)
Figure 48. World Swine Atrophic Rhinitis Vaccine Average Price by Target Animal (2021-2032) & (US$/Dose)
Figure 49. World Swine Atrophic Rhinitis Vaccine Production Value by Dose Pack Size, (USD Million), 2021 & 2025 & 2032
Figure 50. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Dose Pack Size in 2025
Figure 51. Small Pack (Below 20 Doses per Vial)
Figure 52. Medium Pack (20–50 Doses per Vial)
Figure 53. Large Pack (Above 50 Doses per Vial)
Figure 54. World Swine Atrophic Rhinitis Vaccine Production Market Share by Dose Pack Size (2021-2032)
Figure 55. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Dose Pack Size (2021-2032)
Figure 56. World Swine Atrophic Rhinitis Vaccine Average Price by Dose Pack Size (2021-2032) & (US$/Dose)
Figure 57. World Swine Atrophic Rhinitis Vaccine Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Application in 2025
Figure 59. Large-scale Pig Farming Groups
Figure 60. Breeding Pig Farms
Figure 61. Veterinary Service Providers
Figure 62. Others
Figure 63. World Swine Atrophic Rhinitis Vaccine Production Market Share by Application (2021-2032)
Figure 64. World Swine Atrophic Rhinitis Vaccine Production Value Market Share by Application (2021-2032)
Figure 65. World Swine Atrophic Rhinitis Vaccine Average Price by Application (2021-2032) & (US$/Dose)
Figure 66. Swine Atrophic Rhinitis Vaccine Industry Chain
Figure 67. Swine Atrophic Rhinitis Vaccine Procurement Model
Figure 68. Swine Atrophic Rhinitis Vaccine Sales Model
Figure 69. Swine Atrophic Rhinitis Vaccine Sales Channels, Direct Sales, and Distribution
Figure 70. Methodology
Figure 71. Research Process and Data Source
